Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT03563599

A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Dos…

This is a Phase IIa, open-label, randomized study in treatment-naïve, sputum smear-positive patients with drug-sensitive pulmonary TB to assess the early bacter…

South Africa60 participantsStarted 2018-07-23

Treatment: Telacebec (Q203), Rifafour e-275